#
Press Releases

Stay Informed with Our Latest Healthcare Updates and Announcements

Press Releases

Stay Informed with Our Latest Healthcare Updates and Announcements

Asset Publisher

Joan Eliasek Named New President of McKesson Canada

Mississauga, ON - Feb 9, 2023 - McKesson Canada is pleased to announce the appointment of veteran executive Joan Eliasek as President of McKesson Canada. Eliasek succeeds Rebecca McKillican who has led the company since August 2020.

Eliasek’s wealth of leadership experience spans over 25 years within the healthcare sector and McKesson Corporation, having held senior leadership roles in areas ranging from operations, marketing, supplier management to extended care sales and customer experience.

As President, Eliasek leads McKesson's diversified portfolio of healthcare businesses in Canada including pharmaceutical distribution operations, biopharma and provider solutions, McKesson's network of independent pharmacies (I.D.A., Guardian, Remedy'sRx, The Medicine Shoppe, Uniprix and Proxim), e-commerce retailer Well.ca, and the Rexall Pharmacy Group.

“I am honoured to be leading a passionate team dedicated to improving the health outcomes of Canadians,” Eliasek said.  “McKesson Canada is an essential part of the Canadian healthcare system, whether we are delivering much needed medications to patients across the country, strengthening our supply chain systems, or helping patients navigate specialized medication therapies. As healthcare becomes increasingly more complex, our position within the healthcare ecosystem offers us a unique opportunity to make a positive and lasting impact.”

Eliasek holds a Bachelor of Arts degree in Political Science and Business Administration from the University of Iowa. She has served on several boards in the healthcare industry, including the Healthcare Industry Distributors Association (HIDA), the HIDA Educational Foundation and the Global Healthcare Exchange. She also served as a long-time advisor to the Professional Women in Healthcare (PWH) board. In 2018, she was recognized as the first recipient of the Anne Eiting Klamar Leadership Award of Distinction and in 2023 she is being named to the Medical Distributor Hall of Fame by Repertoire Magazine.

 

About McKesson Canada

McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.

Publish Date
2/9/23

McKesson Canada’s independent pharmacies Guardian, I.D.A., Remedy’sRx and The Medicine Shoppe Pharmacies welcome decision to prescribe for minor ailments

Mississauga, ON (January 17, 2023) - Pharmacists at McKesson Canada’s independent pharmacy network including Guardian, I.D.A, Remedy'sRx and The Medicine Shoppe in Ontario can now prescribe and treat 13 minor conditions, including cold sores, pink eye, hemorrhoids, hives and urinary tract infections, among others.

Patients can now walk into their local pharmacy and receive assessment and treatment from their pharmacist for the following 13 conditions:

  • hay fever
  • oral thrush
  • pink eye
  • dermatitis
  • menstrual cramps
  • acid reflux 
  • hemorrhoids
  • cold sores
  • impetigo
  • insect bites and hives
  • tick bites
  • sprains and strains
  • urinary tract infections (UTIs)

 

By allowing pharmacists to support patients with these needs, it increases access to quality care and takes pressure off the health system like hospitals, primary care clinics and emergency rooms.

 

"Our independent pharmacists at Guardian, I.D.A., Remedy'sRx and The Medicine Shoppe are standing by to help provide greater convenience and choice for their patients to obtain quality healthcare services where they need them the most,” says Smita Patil, Vice President, Retail Member Relations and Professional Affairs at McKesson Canada. “By using their expertise to assess and treat minor conditions, pharmacists help patients get the care they need sooner and closer to home.”

 

About McKesson Canada

McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver products, services and insights to help make quality care more accessible and affordable.

Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca

 

For more information:
Andrew Campbell
Media Relations
media@mckesson.ca

Publish Date
1/17/23

McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes

McKesson EvolveHealth Digital Ecosystem offers innovative solutions at every step of the specialty patient journey

MISSISSAUGA, ON, Nov. 17, 2022 - McKesson Canada's Biopharma and Provider Solutions business is proud to share the launch of McKesson's EvolveHealth Digital Ecosystem (EvolveHealth). EvolveHealth is a suite of digital solutions designed to seamlessly connect health care providers, private payers, specialty patients, and pharmaceutical companies to help simplify and enhance the patient experience and deliver better patient outcomes.

McKesson Canada (CNW Group/MCKESSON CANADA)

 

One of the ongoing challenges faced by both health care providers and Canadians affected by rare or complex diseases, is navigating a complex system which can sometimes delay access to life-saving therapeutic treatments. To better support health care providers and specialty patients, EvolveHealth offers innovative solutions that help alleviate these challenges and create a more accessible, specialized, and personalized care journey.

As a digital suite, EvolveHealth supports patients at every step of their journey. It simplifies their access to treatment, streamlines financial assistance and co-pays, enhances adherence to treatment plans and provides patients with data and insights on their progress to improve outcomes. For health care providers and pharmaceutical companies, EvolveHealth delivers actionable insights, offers seamless communication between different teams and individuals, and highlights real-world evidence to help improve patient care and outcomes. EvolveHealth also builds on McKesson Canada's partnerships with leading health technology and platforms like KEEP (the award-winning modern medicine cabinet for complex medication management) to help simplify access to treatment and help improve the patient experience.

"McKesson Canada is proud to be a long-standing partner to the pharmaceutical industry, and we're excited to introduce the EvolveHealth Digital Ecosystem as part of our aspiration to improve patient outcomes," said Ramy Ayad, Senior Vice-President, Biopharma and Provider Solutions. "This is a digital suite aimed at improving care for specialty patients, while simultaneously enhancing health care providers, pharmaceutical companies and private payer efficiencies and managing complexities related to specialty medications and treatments."

Digital innovations and solutions to simplify and improve patient outcomes is a foundational pillar for McKesson Canada's Biopharma and Provider Solutions teams. McKesson Canada is focused on harnessing EvolveHealth to positively impact the lives of Canadians and advancing better health outcomes for all.

About McKesson Canada

McKesson Canada is a diversified health-care services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with pharmaceutical companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of health care at www.McKesson.ca

 

For further information: Andrew Campbell, Media Relations, media@mckesson.ca

Publish Date
11/17/22

McKesson Canada's Independent Pharmacies Guardian, I.D.A., Remedy’sRx and The Medicine Shoppe Pharmacies Launch Annual Flu Vaccination Campaigns

Today, McKesson Canada’s retail banner group pharmacies, including Guardian, I.D.A, Remedy'sRx and The Medicine Shoppe launched their annual flu shot campaign.

 “Our independently owned community pharmacies are ready to deliver the flu vaccine to Canadians who wish to protect themselves and their loved ones,” said Smita Patil, Vice-President of Retail Member Relations and Professional Affairs, McKesson Canada. “Canadians should feel assured knowing their local pharmacist will be able to provide flu shots with high quality care, knowledge, and a safe environment that prioritizes the health and well-being of patients.”

Every year, tens of thousands of Canadians get sick with the flu. While most people will recover after contracting the flu, it can be life-threating for people at high risk such as children, seniors, and those with chronic health conditions.

Getting vaccinated against the flu every year is an important part of keeping Canadians healthy. The vaccine not only protects individuals against some strains of the virus, but also reduces the severity of symptoms for those who do get the flu.  It takes a community to prevent the spread of influenza and for about every 20 people that get a vaccine, one case is prevented.

Our Independent community pharmacies are proud to play a vital role in the Canadian healthcare industry and in our greater society. Contact your local community pharmacist today to schedule your free flu vaccine. Make an appointment today by visiting the websites of GuardianI.D.ARemedy'sRx or The Medicine Shoppe to find the closest pharmacy near you. Availability by province and pharmacy location may vary.

 

About McKesson Canada

McKesson Canada is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson Canada is impacting virtually every aspect of healthcare at www.McKesson.ca.

 

For more information:

Andrew Campbell

Media Relations

media@mckesson.ca

Publish Date
10/13/22

Les pharmacies affiliées à Proxim et Uniprix lancent leur campagne annuelle de vaccination contre la grippe

Montréal (Québec), le 5 octobre 2022 — Les pharmacies affiliées à Proxim et Uniprix lancent leur campagne annuelle de vaccination contre la grippe.

« Au cours des dernières années, nos pharmaciens communautaires ont su démontrer qu’ils sont partie intégrante du système de santé québécois », a déclaré Erick Gagné, président-directeur général, Proxim et Uniprix. « Après avoir participé à l’effort de vaccination contre la COVID-19, les pharmaciens sont prêts, encore cette année, à vacciner les Québécois qui souhaitent se protéger et protéger leurs proches contre la grippe. »

L'activité grippale dans l'hémisphère Sud ayant été plus précoce par rapport aux années précédentes, la campagne de vaccination contre l'influenza a été devancée cette année et débutera le 5 octobre. Chaque année, des milliers de Québécois souffrent de la grippe, ce qui engorge davantage les hôpitaux et le système de santé. Bien que la plupart des gens se rétablissent après avoir contracté la grippe, celle-ci peut menacer la vie des personnes à risque, notamment celle des enfants, des aînés et des personnes atteintes de maladies chroniques.

Consultez les sites internet de Proxim et d’Uniprix afin de prendre votre rendez-vous dès aujourd’hui dans la pharmacie la plus près de chez vous. Profitez-en pour recevoir, en même temps et de façon sécuritaire, le vaccin contre la COVID-19.

*Les pharmaciens propriétaires affiliés à Proxim et Uniprix sont les seuls responsables de l’exercice de la pharmacie.

 

À propos de McKesson Canada

McKesson Canada est un chef de file diversifié en matière de services de soins de santé qui se consacre à l’avancement des résultats relatifs à la santé des patients du monde entier. Nos équipes collaborent avec les sociétés biopharmaceutiques, les fournisseurs de soins, les pharmacies, les fabricants, les gouvernements et d’autres intervenants afin de fournir des perspectives, des produits et des services permettant de rendre les soins de qualité plus accessibles et abordables. Apprenez-en davantage sur l’impact de McKesson Canada sur pratiquement tous les aspects des soins de santé sur www.mckesson.ca.

 

Renseignements

Melissa Turgeon

Relations médias pour le Québec

media@mckesson.ca

(514) 601-7280

Publish Date
10/5/22
White Papers
image
Rare Disease Drugs in Canada: Considerations for Equitable Access

A significant public policy priority for the Government of Canada is ensuring comprehensive, timely, and equitable access to medication for rare diseases; as such, the Government of Canada has allocated $500 million annually to a national strategy for rare disease drugs. McKesson Canada is proud to contribute to this conversation, drawing on experience with patient support programs, pharmaceutical distribution, and specialty pharmacy services. 

image
The $100 Solution: A PostPandemic Path Forward for National Pharmacare in Canada

The Government of Canada would like to develop a solution to ensure universal drug coverage for Canadians. This solution would mean all Canadians would have access to a comprehensive, affordable drug insurance plan regardless of their province of residence or financial situation. Where the coverage comes from is an important consideration, but what ultimately matters is that all Canadians can acquire the medicine they need regardless of their particular financial, geographic or health circumstances. 

image
From Pandemic to Endemic: Lessons from COVID-19 on Improving Vaccination Campaigns in Canada

During the COVID-19 pandemic in Canada, it became clear that any return to 'normal' would only be possible once the majority of Canadians received vaccines. At the time, a COVID-19 vaccine existed only in the designs of biomedical scientists, and most did not anticipate a mass-market vaccine arriving for at least 18 months. In addition to developing the vaccine, the pharmaceutical sector had to conquer the challenge of manufacturing, transporting, storing, and administering billions of doses.